Literature DB >> 12672690

Genomic instability and endoreduplication triggered by RAD17 deletion.

Xin Wang1, Lee Zou, Huyong Zheng, Qingyi Wei, Stephen J Elledge, Lei Li.   

Abstract

Cell cycle checkpoints are critical for genomic stability. Rad17, a component of the checkpoint clamp loader complex (Rad17/Rfc2-5), is required for the response to DNA damage and replication stress. To explore the role of Rad17 in the maintenance of genomic integrity, we established somatic conditional alleles of RAD17 in human cells. We find that RAD17 is not only important for the Atr-mediated checkpoint but is also essential for cell viability. Cells lacking RAD17 exhibited acute chromosomal aberrations and underwent endoreduplication at a high rate. Therefore, RAD17 links the checkpoint to ploidy control and is essential for the maintenance of chromosomal stability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672690      PMCID: PMC196036          DOI: 10.1101/gad.1065103

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  29 in total

1.  Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin.

Authors:  Lee Zou; David Cortez; Stephen J Elledge
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

2.  Structure-function analysis of fission yeast Hus1-Rad1-Rad9 checkpoint complex.

Authors:  R Kaur; C F Kostrub; T Enoch
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

3.  SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.

Authors:  Parvin T Yazdi; Yi Wang; Song Zhao; Nimitt Patel; Eva Y-H P Lee; Jun Qin
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

4.  Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.

Authors:  Seong-Tae Kim; Bo Xu; Michael B Kastan
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

5.  Two checkpoint complexes are independently recruited to sites of DNA damage in vivo.

Authors:  J A Melo; J Cohen; D P Toczyski
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

6.  Purification and characterization of human DNA damage checkpoint Rad complexes.

Authors:  L A Lindsey-Boltz; V P Bermudez; J Hurwitz; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 7.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

8.  ATR and ATRIP: partners in checkpoint signaling.

Authors:  D Cortez; S Guntuku; J Qin; S J Elledge
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

9.  Recruitment of Mec1 and Ddc1 checkpoint proteins to double-strand breaks through distinct mechanisms.

Authors:  T Kondo; T Wakayama; T Naiki; K Matsumoto; K Sugimoto
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

Review 10.  Replication licensing--defining the proliferative state?

Authors:  J Julian Blow; Ben Hodgson
Journal:  Trends Cell Biol       Date:  2002-02       Impact factor: 20.808

View more
  29 in total

1.  Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response.

Authors:  Xiaoshan Zhang; Janice Succi; Zhaohui Feng; Sheela Prithivirajsingh; Michael D Story; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress.

Authors:  Liyong Zhang; Chi-Hoon Park; Jing Wu; Hyun Kim; Weijun Liu; Takeo Fujita; Manimalha Balasubramani; Emanuel M Schreiber; Xiao-Fan Wang; Yong Wan
Journal:  EMBO J       Date:  2010-04-27       Impact factor: 11.598

3.  Persistent telomere damage induces bypass of mitosis and tetraploidy.

Authors:  Teresa Davoli; Eros Lazzerini Denchi; Titia de Lange
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

4.  Increased common fragile site expression, cell proliferation defects, and apoptosis following conditional inactivation of mouse Hus1 in primary cultured cells.

Authors:  Min Zhu; Robert S Weiss
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

5.  Specific role of Chk1 phosphorylations in cell survival and checkpoint activation.

Authors:  Hiroyuki Niida; Yuko Katsuno; Birendranath Banerjee; M Prakash Hande; Makoto Nakanishi
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

6.  Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy.

Authors:  Lova Rakotomalala; Leo Studach; Wen-Horng Wang; Gerald Gregori; Ronald L Hullinger; Ourania Andrisani
Journal:  J Biol Chem       Date:  2008-08-08       Impact factor: 5.157

7.  Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins.

Authors:  C L Meyerkord; Y Takahashi; R Araya; N Takada; R S Weiss; H-G Wang
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

8.  ATR regulates hexavalent chromium-induced S-phase checkpoint through phosphorylation of SMC1.

Authors:  Timothy P Wakeman; Bo Xu
Journal:  Mutat Res       Date:  2006-07-27       Impact factor: 2.433

9.  Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Authors:  Naiyer A Rizvi; Matthew D Hellmann; Alexandra Snyder; Pia Kvistborg; Vladimir Makarov; Jonathan J Havel; William Lee; Jianda Yuan; Phillip Wong; Teresa S Ho; Martin L Miller; Natasha Rekhtman; Andre L Moreira; Fawzia Ibrahim; Cameron Bruggeman; Billel Gasmi; Roberta Zappasodi; Yuka Maeda; Chris Sander; Edward B Garon; Taha Merghoub; Jedd D Wolchok; Ton N Schumacher; Timothy A Chan
Journal:  Science       Date:  2015-03-12       Impact factor: 47.728

10.  MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation.

Authors:  Yi Wang; Jun Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.